Clinical Trials

NCT IdNCT04107207
TitleEvaluating the Effects of Kombucha as a Hyperglycemic Therapeutic Agent Within Diabetic Human Subjects
ConditionDiabetes Mellitus
StudyTypeInterventional
OrganizationGeorgetown University
Sponsor/CollaboratorsGeorgetown University
StatusCompleted
GenderAll
AgeGroupAdult
Older Adult
Location (with distance)
  • Georgetown University MedStar Hospital, Washington, 20007 , United States
DescriptionThis study's primary objective is to determine the ability of Kombucha to impact blood sugar levels in patients with diabetes mellitus type II. The secondary objective is to determine the ability of Kombucha to impact blood pressure, and quality of life measures as measured by uniform questionnaire that includes: gut health, colds, infections, headaches, sleep, anxiety (GAD2), depression (PHQ2), skin health.